NCLAT: Can’t Dismiss Restoration App. if Filed in 30 Days from Date of Dismissal of Original App. || Delhi HC: Communication between Parties through Whatsapp Constitute Valid Agreement || Delhi HC Seeks Response from Govt. Over Penalties on Petrol Pumps Supplying Fuel to Old Vehicles || Centre Notifies "Unified Waqf Management, Empowerment, Efficiency and Development Rules, 2025" || Del. HC: Can’t Reject TM Owner’s Claim Merely because Defendant Could have Sought Removal of Mark || Bombay HC: Cannot Treat Sole Director of OPC, Parallelly with Separate Legal Entity || Delhi HC: Can Apply 'Family of Marks' Concept to Injunct Specific Marks || HP HC: Can’t Set Aside Ex-Parte Decree for Mere Irregularity || Cal. HC: Order by HC Bench Not Conferred With Determination by Roster is Void || Calcutta HC: Purchase Order Including Arbitration Agreement to Prevail Over Tax Invoice Lacking it

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS

Share :